Acadia Healthcare (NASDAQ:ACHC) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Acadia Healthcare (NASDAQ:ACHC) posted its quarterly earnings results on Thursday. The company reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.11), Zacks reports. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare updated its Q1 2025 guidance to EPS and its FY 2025 guidance to 2.500-2.800 EPS.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded down $0.74 during midday trading on Thursday, reaching $40.26. The stock had a trading volume of 2,625,423 shares, compared to its average volume of 1,419,476. The firm has a market capitalization of $3.74 billion, a PE ratio of 13.20, a P/E/G ratio of 1.46 and a beta of 1.30. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $86.67. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm’s 50-day moving average price is $42.22 and its 200 day moving average price is $52.30.

Analysts Set New Price Targets

ACHC has been the subject of a number of recent research reports. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. Barclays dropped their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a research report on Tuesday, January 7th. Finally, TD Cowen lowered their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.